United States Outpatient Medical Imaging Group Lumexa Imaging Nasdaq IPO Share Price Increased +0.1% on Day 1 Trading (11/12/25 IPO Price: $18.5, Closing $18.53) to $1.7 Billion Market Value & Raised $462.5 Million in IPO, Founded in 2018 as US Radiology Specialists by Charlotte Radiology & Private Equity Firm WCAS (Welsh, Carson, Anderson & Stowe), Renamed to Lumexa Imaging in 2025 July
16th December | Hong Kong
United States outpatient medical imaging Group Lumexa Imaging Nasdaq IPO share price increased +0.1% on day 1 trading (11/12/25 ipo price: $18.5, closing $18.53) to $1.7 billion market value, raising $462.5 million in the IPO. In 2025 December, Lumexa Imaging Nasdaq IPO was raising $500 million at $1.9 billion valuation, with expected IPO listing on 11th December 2025. Lumexa Imaging was founded in 2018 as US Radiology Specialists by Charlotte Radiology & private equity firm WCAS (Welsh, Carson, Anderson & Stowe), and renamed to Lumexa Imaging in 2025 July. Lumexa Imaging – Lumexa Imaging is one of the nation’s largest providers of outpatient medical imaging, with a mission to expand access to advanced, high-quality, and affordable diagnostic care. We operate more than 180 centers across 13 states, including more than 85 centers in joint ventures with leading health systems. With over 5,000 team members and a clinical network of more than 1,000 subspecialized radiologists, we perform over 4 million outpatient studies each year. Lumexa Imaging is the partner of choice for health systems and radiologists, delivering best-in-class clinical excellence, operations, and state-of-the-art technology across our platform. As the healthcare landscape shifts toward more convenient, lower-cost outpatient solutions, Lumexa Imaging is uniquely positioned to meet this growing demand, bringing clarity, comfort, and compassionate care to more patients in more communities.
“ United States Outpatient Medical Imaging Group Lumexa Imaging Nasdaq IPO Share Price Increased +0.1% on Day 1 Trading (11/12/25 IPO Price: $18.5, Closing $18.53) to $1.7 Billion Market Value & Raised $462.5 Million in IPO, Founded in 2018 as US Radiology Specialists by Charlotte Radiology & Private Equity Firm WCAS (Welsh, Carson, Anderson & Stowe), Renamed to Lumexa Imaging in 2025 July “
![](https://www.caproasia.com/wp-content/uploads/2025/08/Air-Charter-Service-728x90-1.png")
United States Outpatient Medical Imaging Group Lumexa Imaging Nasdaq IPO to Raise $500 Million at $1.9 Billion Valuation with Expected IPO Listing on 11th December 2025, Founded in 2018 as US Radiology Specialists by Charlotte Radiology & Private Equity Firm WCAS (Welsh, Carson, Anderson & Stowe), Renamed to Lumexa Imaging in 2025 July
9th December – United States outpatient medical imaging Group Lumexa Imaging Nasdaq IPO is raising $500 million at $1.9 billion valuation, with expected IPO listing on 11th December 2025. Lumexa Imaging was founded in 2018 as US Radiology Specialists by Charlotte Radiology & private equity firm WCAS (Welsh, Carson, Anderson & Stowe), and renamed to Lumexa Imaging in 2025 July. Lumexa Imaging – Lumexa Imaging is one of the nation’s largest providers of outpatient medical imaging, with a mission to expand access to advanced, high-quality, and affordable diagnostic care. We operate more than 180 centers across 13 states, including more than 85 centers in joint ventures with leading health systems. With over 5,000 team members and a clinical network of more than 1,000 subspecialized radiologists, we perform over 4 million outpatient studies each year. Lumexa Imaging is the partner of choice for health systems and radiologists, delivering best-in-class clinical excellence, operations, and state-of-the-art technology across our platform. As the healthcare landscape shifts toward more convenient, lower-cost outpatient solutions, Lumexa Imaging is uniquely positioned to meet this growing demand, bringing clarity, comfort, and compassionate care to more patients in more communities.
Caproasia Users
- Manage $20 million to $30 billion of assets
- Invest $3 million to $300 million
- Advise institutions, billionaires, UHNWs & HNWs
Caproasia Platforms | 11,000 Investors & Advisors
- Caproasia.com
- Caproasia Access
- Caproasia Events
- The Financial Centre | Find Services
- Membership
- Family Office Circle
- Professional Investor Circle
- Investor Relations Network
Monthly Roundtable & Networking
Family Office Programs
The 2026 Investment Day
- March - Hong Kong
- March - Singapore
- April - Hong Kong
- April - Singapore
- July - Hong Kong
- July - Singapore
- Sept- Hong Kong
- Sept - Singapore
- Oct- Hong Kong
- Nov - Singapore
- Visit: The Investment Day | Register: Click here
Caproasia Summits
- The Institutional Investor Summit
- The Investment / Alternatives Summit
- The Private Wealth Summit
- The Family Office Summit
- The CEO & Entrepreneur Summit
- The Capital Markets Summit
- The ESG / Sustainable Investment Summit
